Inhaled Insulin Clears Hurdle Toward F.D.A. Approval
Wednesday, April 2, 2014 - 18:40
in Health & Medicine
The product, called Afrezza, would offer people with diabetes a treatment option that does not require injections, although its success in clinical trials has been modest at best.